Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 20.15% is 81% above its 5-year average of 11.12%, near the high end of its 5-year range (-16.74%–21.46%).
As of the fiscal period ended Tuesday, March 31, 2026. 17.18% above its 12-month average of 17.19%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
20.15%
NET PROFIT MARGIN AVG TTM
17.19%
NET PROFIT MARGIN AVG 3Y
15.03%
NET PROFIT MARGIN AVG 5Y
12.51%
NET PROFIT MARGIN AVG 10Y
11.26%
NET PROFIT MARGIN AVG 15Y
12.22%
NET PROFIT MARGIN AVG 20Y
15.21%
CURRENT VS TTM AVG
+17.18%
CURRENT VS 3Y AVG
+34.06%
CURRENT VS 5Y AVG
+61.05%
CURRENT VS 10Y AVG
+78.91%
CURRENT VS 15Y AVG
+64.87%
CURRENT VS 20Y AVG
+32.43%
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+92.97%
vs the sector median at left
AstraZeneca PLC
Market Cap
$132.52B
Net Profit Margin
20.15%
TTM Avg
17.19%
3Y Avg
15.03%
5Y Avg
12.51%
Market Cap
$135.51B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$128.82B
Net Profit Margin
13.21%
TTM Avg
13.09%
3Y Avg
13.60%
5Y Avg
12.87%
Market Cap
$128.13B
Net Profit Margin
15.01%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.59%
Market Cap
$125.77B
Net Profit Margin
28.45%
TTM Avg
28.09%
3Y Avg
25.67%
5Y Avg
26.14%
Market Cap
$122.36B
Net Profit Margin
35.40%
TTM Avg
13.94%
3Y Avg
25.44%
5Y Avg
29.40%
Market Cap
$108.75B
Net Profit Margin
13.20%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $132.52B | 20.15% | 17.19% | 15.03% | 12.51% |
| Danaher Corporation (DHR)vs › | $135.51B | 15.95% | 15.52% | 19.51% | 19.37% |
| CVS Health Corp. (CVS)vs › | $136.46B | 0.72% | 0.84% | 1.34% | 1.79% |
| Stryker Corporation (SYK)vs › | $128.82B | 13.21% | 13.09% | 13.60% | 12.87% |
| Bristol-Myers Squibb Company (BMY)vs › | $128.13B | 15.01% | -1.95% | 6.91% | 3.59% |
| Intuitive Surgical, Inc. (ISRG)vs › | $125.77B | 28.45% | 28.09% | 25.67% | 26.14% |
| Pfizer Inc. (PFE)vs › | $141.09B | 11.83% | 12.51% | 14.97% | 18.18% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $122.36B | 35.40% | 13.94% | 25.44% | 29.40% |
| Medtronic plc (MDT)vs › | $108.75B | 13.20% | 13.55% | 12.62% | 13.06% |
| GSK plc (GSK)vs › | $105.03B | 17.76% | 12.86% | 23.24% | 22.39% |
Operating Margin
23.7%
Net Profit Margin
20.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 20.15% |
| 2025-12-31 | 15.00% |
| 2025-09-30 | 16.67% |
| 2025-06-30 | 16.95% |
| 2025-03-30 | 21.46% |
| 2024-12-31 | 10.07% |
| 2024-09-30 | 10.53% |
| 2024-06-30 | 14.89% |
| 2024-03-31 | 17.19% |
| 2023-12-31 | 7.98% |
| 2023-09-30 | 11.96% |
| 2023-06-30 | 15.93% |
| 2023-03-31 | 16.57% |
| 2022-12-31 | 8.04% |
| 2022-09-30 | 14.93% |
| 2022-06-30 | 3.34% |
| 2022-03-31 | 3.39% |
| 2021-12-31 | -2.89% |
| 2021-09-30 | -16.74% |
| 2021-06-30 | 6.69% |
| 2021-03-31 | 21.33% |
| 2020-12-31 | 13.66% |
| 2020-09-30 | 9.85% |
| 2020-06-30 | 12.05% |
| 2020-03-31 | 12.28% |
| 2019-12-31 | 4.70% |
| 2019-09-30 | 4.67% |
| 2019-06-30 | 2.23% |
| 2019-03-31 | 10.80% |
| 2018-12-31 | 16.11% |
| 2018-09-30 | 8.07% |
| 2018-06-30 | 6.79% |
| 2018-03-31 | 6.57% |
| 2017-12-31 | 22.52% |
| 2017-09-30 | 11.01% |
| 2017-06-30 | 9.44% |
| 2017-03-31 | 9.94% |
| 2016-12-31 | 32.98% |
| 2016-09-30 | 17.79% |
| 2016-06-30 | -0.05% |
| 2016-03-31 | 10.56% |
| 2015-12-31 | 12.63% |
| 2015-09-30 | 12.95% |
| 2015-06-30 | 11.05% |
| 2015-03-31 | 9.08% |
| 2014-12-31 | -4.80% |
| 2014-09-30 | 3.84% |
| 2014-06-30 | 11.77% |
| 2014-03-31 | 7.80% |
| 2013-12-31 | -7.66% |
| 2013-09-30 | 19.94% |
| 2013-06-30 | 13.21% |
| 2013-03-31 | 15.83% |
| 2012-12-31 | 20.89% |
| 2012-09-30 | 22.61% |
| 2012-06-30 | 23.98% |
| 2012-03-31 | 22.11% |
| 2011-12-31 | 17.17% |
| 2011-09-30 | 42.34% |
| 2011-06-30 | 25.07% |
| 2011-03-31 | 35.06% |
| 2010-12-31 | 18.81% |
| 2010-09-30 | 19.60% |
| 2010-06-30 | 25.76% |
| 2010-03-31 | 32.38% |
| 2009-12-31 | 17.36% |
| 2009-09-30 | 25.79% |
| 2009-06-30 | 21.45% |
| 2009-03-31 | 27.87% |
| 2008-12-31 | 15.23% |
| 2008-09-30 | 22.25% |
| 2008-06-30 | 20.36% |
| 2008-03-31 | 19.58% |
| 2007-12-31 | 15.50% |
| 2007-09-30 | 18.78% |
| 2007-06-30 | 19.61% |
| 2007-03-31 | 22.39% |
| 2006-12-31 | 20.02% |
| 2006-09-30 | 24.36% |
| 2006-06-30 | 24.14% |
| 2006-03-31 | 23.04% |
| 2005-12-31 | 19.47% |
| 2005-09-30 | 21.13% |
| 2005-06-30 | 19.88% |
| 2005-03-31 | 18.11% |
| 2004-12-31 | 18.49% |
| 2004-09-30 | 21.52% |
| 2004-06-30 | 15.34% |
| 2004-03-31 | 15.71% |
| 2003-12-31 | 13.03% |
| 2003-09-30 | 16.71% |
| 2003-06-30 | 15.02% |
| 2003-03-31 | 19.68% |
| 2002-12-31 | 9.19% |
| 2002-09-30 | 15.45% |
| 2002-06-30 | 17.97% |
